Endpoints News
Acting FDA chief not interested in permanent role Read in browser
Endpoints News
Thank you for reading, dupa dupackia!
basic
UPGRADE
M T W Th Fri
5 June, 2026
The Endpoints 100: Despite all the turmoil, biotech is having a moment
A year ago, biotech was in its bleakest stretch in a decade. Now IPOs are rebounding and China deals are heating up. John Carroll and a panel of industry leaders dig into the latest Endpoints 100 results and uncover what’s next for the sector.
news
Otsuka touts new IgAN evidence as it seeks full approval for Voyxact
ENDPOINTS NEWS
Acting FDA chief isn't interested in permanent role
ENDPOINTS NEWS
 
Acting FDA commissioner pledges to prevent political interference in rare disease meeting
ENDPOINTS NEWS
Peer Review
Novo vet Uli Stilz settles in at Flagship; Revolution Medicines welcomes commercial exec
ENDPOINTS NEWS
LGBTQ+ LEADERSHIP IN 2026
LGBTQ+ diversity drives innovation in biopharma — but transgender and non-binary professionals face rising challenges. Endpoints is going live with our fourth annual special report celebrating the honorees giving voice and visibility while forging ahead across life sciences. Join us.
Pharma
Corrected: Mammalian hair, roof leaks: Novo Nordisk's site in Indiana under FDA scrutiny once again
ENDPOINTS NEWS
Dimension seeks up to $750M for third life sciences fund after portfolio hot streak
ENDPOINTS NEWS
Updated: Supreme Court sides with Hikma in 'skinny label' case
ENDPOINTS NEWS
in case you missed it
1.
Germany’s health-spending plan has consequences as Lilly, Boehringer scale back
ENDPOINTS NEWS
2.
Parabilis Medicines charts $413M IPO to back peptide pipeline
ENDPOINTS NEWS
3.
News Briefing
Novo Holdings backs European fund; Alnylam sends second obesity drug into clinic
ENDPOINTS NEWS
4.
ADC Therapeutics' confirmatory data for Zynlonta muddied by death rates
ENDPOINTS NEWS
5.
Alnylam signs its first AI discovery deal with RNA specialist Inceptive
ENDPOINTS NEWS
6.
ADC biotech Ona Therapeutics secures $86.6M in Series B raise
ENDPOINTS NEWS
7.
Roche chairman likens US tariff policy to 'blackmail'
REUTERS
8.
Ebola Pioneer Peter Piot on How Worried the World Should Be
BLOOMBERG
Reynald Castaneda
.

The American Diabetes Association's Scientific Sessions start today in New Orleans, with companies like Roche, Novo Nordisk and Pfizer taking the stage. Stay tuned for Elizabeth Cairns' remote coverage over the weekend with a newsletter on Sunday.

.
Reynald Castaneda
Deputy Editor, Endpoints News
Endpoints News
2029 Becker Drive; Lawrence, Kansas 66047 USA Privacy and deletion: help@endpointsnews.com
web twitter linkedin